USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	055181/0119			Pages:	10
		Recorded:	02/08/2021
Attorney Dkt #:	I071-0088TP
Conveyance:	ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 22

Patent #:	9572837	Issue Dt:	02/21/2017	Application #:	15093643	Filing Dt:	04/07/2016
Publication #:	US20160256488	Pub Dt:	09/08/2016
Title:	Reducing Immune Tolerance Induced by PD-L1

Patent #:	10619136	Issue Dt:	04/14/2020	Application #:	15373012	Filing Dt:	12/08/2016
Publication #:	US20170096638	Pub Dt:	04/06/2017
Title:	Reducing Immune Tolerance Induced by PD-L1

Patent #:	9932405	Issue Dt:	04/03/2018	Application #:	15685670	Filing Dt:	08/24/2017
Publication #:	US20170355776	Pub Dt:	12/14/2017
Title:	USE OF CHIMERIC ANTIGEN RECEPTOR MODIFIED CELLS TO TREAT CANCER

Patent #:	10493139	Issue Dt:	12/03/2019	Application #:	15876538	Filing Dt:	01/22/2018
Publication #:	US20180153977	Pub Dt:	06/07/2018
Title:	HUMANIZED ANTI-CD19 ANTIBODY AND USE THEREOF WITH CHIMERIC ANTIGEN RECEPTOR

Patent #:	10654934	Issue Dt:	05/19/2020	Application #:	15897743	Filing Dt:	02/15/2018
Publication #:	US20180179289	Pub Dt:	06/28/2018
Title:	USE OF CHIMERIC ANTIGEN RECEPTOR MODIFIED CELLS TO TREAT CANCER

Patent #:	NONE	Issue Dt:		Application #:	15939402	Filing Dt:	03/29/2018
Publication #:	US20180223255	Pub Dt:	08/09/2018
Title:	Activation and Expansion of T Cells

Patent #:	10793638	Issue Dt:	10/06/2020	Application #:	15942112	Filing Dt:	03/30/2018
Publication #:	US20180222995	Pub Dt:	08/09/2018
Title:	USE OF CHIMERIC ANTIGEN RECEPTOR MODIFIED CELLS TO TREAT CANCER

Patent #:	11566223	Issue Dt:	01/31/2023	Application #:	15992833	Filing Dt:	05/30/2018
Publication #:	US20180346876	Pub Dt:	12/06/2018
Title:	Chimeric Antigen Receptor Cell Preparation and Uses Thereof

Patent #:	11235004	Issue Dt:	02/01/2022	Application #:	16023310	Filing Dt:	06/29/2018
Publication #:	US20190000878	Pub Dt:	01/03/2019
Title:	Lymphocyte Cell Lines and Uses Thereof

Patent #:	10561686	Issue Dt:	02/18/2020	Application #:	16146218	Filing Dt:	09/28/2018
Publication #:	US20190216851	Pub Dt:	07/18/2019
Title:	MODIFIED CELL EXPANSION AND USES THEREOF

Patent #:	11008556	Issue Dt:	05/18/2021	Application #:	16157545	Filing Dt:	10/11/2018
Publication #:	US20190125798	Pub Dt:	05/02/2019
Title:	Chimeric antigen receptor (CAR) and T cell receptor (TCR) Modified T cells

Patent #:	10869888	Issue Dt:	12/22/2020	Application #:	16387166	Filing Dt:	04/17/2019
Publication #:	US20190314411	Pub Dt:	10/17/2019
Title:	Modified Cell Expansion and Uses Thereof

Patent #:	10865382	Issue Dt:	12/15/2020	Application #:	16404349	Filing Dt:	05/06/2019
Publication #:	US20190316086	Pub Dt:	10/17/2019
Title:	REDUCING IMMUNE TOLERANCE INDUCED BY PD-L1

Patent #:	10918667	Issue Dt:	02/16/2021	Application #:	16445965	Filing Dt:	06/19/2019
Publication #:	US20200155598	Pub Dt:	05/21/2020
Title:	Modified Cell Expressing Therapeutic Agent and Uses thereof

Patent #:	11866494	Issue Dt:	01/09/2024	Application #:	16552521	Filing Dt:	08/27/2019
Publication #:	US20200071400	Pub Dt:	03/05/2020
Title:	CAR T Therapy through Uses of Co-stimulation

Patent #:	11701385	Issue Dt:	07/18/2023	Application #:	16555198	Filing Dt:	08/29/2019
Publication #:	US20200069732	Pub Dt:	03/05/2020
Title:	MODULATION OF CELL FUNCTION FOR IMMUNOTHERAPY

Patent #:	11690874	Issue Dt:	07/04/2023	Application #:	16568799	Filing Dt:	09/12/2019
Publication #:	US20200078403	Pub Dt:	03/12/2020
Title:	Use of Chimeric Antigen Receptor Modified Cells to Treat Autoimmune Disease

Patent #:	11364289	Issue Dt:	06/21/2022	Application #:	16600064	Filing Dt:	10/11/2019
Publication #:	US20200030424	Pub Dt:	01/30/2020
Title:	HUMANIZED ANTI-CD19 ANTIBODY AND USE THEREOF WITH CHIMERIC ANTIGEN RECEPTOR

Patent #:	NONE	Issue Dt:		Application #:	16961418	Filing Dt:	07/10/2020
Publication #:	US20220265708	Pub Dt:	08/25/2022
Title:	Modified Cell Expansion and Uses Thereof

Patent #:	11932700	Issue Dt:	03/19/2024	Application #:	16997553	Filing Dt:	08/19/2020
Publication #:	US20200385484	Pub Dt:	12/10/2020
Title:	USE OF CHIMERIC ANTIGEN RECEPTOR MODIFIED CELLS TO TREAT CANCER

Patent #:	11932873	Issue Dt:	03/19/2024	Application #:	17101780	Filing Dt:	11/23/2020
Publication #:	US20210079349	Pub Dt:	03/18/2021
Title:	Reducing Immune Tolerance Induced by PD-L1

Patent #:	NONE	Issue Dt:		Application #:	17108076	Filing Dt:	12/01/2020
Publication #:	US20210077532	Pub Dt:	03/18/2021
Title:	Modified Cell Expansion and Uses Thereof

Assignor

Exec Dt:

01/18/2021

Assignee

SUITE #5-204, 23 LINE TREE BAY AVENUE

P.O. BOX 2547

GRAND CAYMAN, CAYMAN ISLANDS KY1-1104

Correspondence name and address
	LEE & HAYES, P.C.
	601 WEST RIVERSIDE AVENUE
	SUITE 1400
	SPOKANE, WA 99201

Search Results as of: 05/24/2024 02:59 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6